Personalized prescription of tyrosine kinase inhibitors in unresectable metastatic cholangiocarcinoma.

Autor: Poddubskaya EV; 1I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, 119991 Russia.; Clinical Center Vitamed, 10, Seslavinskaya St., Moscow, 121309 Russia., Baranova MP; Clinical Center Vitamed, 10, Seslavinskaya St., Moscow, 121309 Russia., Allina DO; Pathology Department, Morozov Children's City Hospital, 4th Dobryninsky Lane 1/9, Moscow, 119049 Russia., Smirnov PY; 4State Research Center-Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency, Moscow, 123098 Russia., Albert EA; 1I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, 119991 Russia., Kirilchev AP; 4State Research Center-Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency, Moscow, 123098 Russia., Aleshin AA; 5Stanford University School of Medicine, Stanford, CA 94305 USA., Sekacheva MI; 1I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, 119991 Russia., Suntsova MV; D. Rogachev Federal Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, 117198 Russia.

Publikováno v: Experimental hematology & oncology [Exp Hematol Oncol] 2018 Sep 06; Vol. 7, pp. 21. Date of Electronic Publication: 2018 Sep 06 (Print Publication: 2018).